Novartis AG
NVSEF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001114448
No open-market purchases or sales by Novartis AG insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $6.28M in total; no superinvestor holds it.
Other share classesNVS
Superinvestors holding NVSEF, Q2 2026
No superinvestor reported holding NVSEF in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of NVSEF each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−99.9%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−40.8%)